Literature DB >> 9562480

Does gastric restriction surgery reduce the risks of metabolic diseases?

A M Wolf1, U Beisiegel, B Kortner, H W Kuhlmann.   

Abstract

BACKGROUND: Certain risk factors for arteriosclerosis are associated with obesity, e.g. hypertension, insulin resistance, the high triglyceride - low HDL pattern. One aim in treating morbid obesity is to reduce these risk factors. This study was designed to follow metabolic risk factors after weight loss in 165 morbidly obese patients who underwent a gastric restriction operation. METHODS AND PATIENTS: Lipid and hormone levels were analyzed before surgery and after 25, 50, 75 and 100% loss of excess weight. Mean cholesterol and triglyceride levels were normal or slightly elevated. HDL cholesterol was also normal (41 mg/dl). Thirty eight percent of the patients had elevated cholesterol and triglyceride levels. Insulin levels were measured as an indicator of potential insulin resistance, and with a mean of 21 microU/ml it was at the upper normal level.
RESULTS: After reaching 75% reduction of overweight in a mean time of 10 months, serum cholesterol levels were unchanged. Serum triglycerides, however, decreased by 35% (P<0.0001) and HDL cholesterol increased by 24% (P<0.0001). Insulin levels decreased to 8 microU/ml (P<0.0001).
CONCLUSION: We found an amelioration in the metabolic parameters in 75% of the patients. Nevertheless morbidly obese patients were found to have fewer abnormalities in lipid and glucose metabolism than expected from data of overweight patients with metabolic syndrome. Further long-term studies with careful evaluation of the metabolic parameters as risk factors in patients with morbid obesity need to be performed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562480     DOI: 10.1381/096089298765554980

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  8 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 2.  Does sustained weight loss reverse the metabolic syndrome?

Authors:  Annie Ferland; Robert H Eckel
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

Review 3.  Evidence-based medicine: open and laparoscopic bariatric surgery.

Authors:  P Gentileschi; S Kini; M Catarci; M Gagner
Journal:  Surg Endosc       Date:  2002-01-04       Impact factor: 4.584

4.  The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients.

Authors:  Anna Maria Wolf; Ulrike Beisiegel
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

Review 5.  A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.

Authors:  Kirstin A Carswell; Ajay P Belgaumkar; Stephanie A Amiel; Ameet G Patel
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

6.  Changes in blood lipid levels following silastic ring vertical gastroplasty.

Authors:  Edward Ram; Tali Vishne; Abraham Magazanik; Gideon Harel; Aliza Zaidman; Gil Ohana; Yefim Rabinovich; Zeev Dreznik
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

7.  Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion.

Authors:  Magdalena Vila; Olga Ruíz; Mar Belmonte; Maria Riesco; Antonia Barceló; Gerardo Perez; Jose Moreiro; Ramon Salinas
Journal:  Obes Surg       Date:  2009-01-06       Impact factor: 4.129

8.  Serum levels of fetal antigen 1 in extreme nutritional States.

Authors:  Alin Andries; Andreas Niemeier; Rene K Støving; Basem M Abdallah; Anna-Maria Wolf; Kirsten Hørder; Moustapha Kassem
Journal:  ISRN Endocrinol       Date:  2012-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.